Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Allgenesis Posts Positive Data from US Trial of Bi-Specific for Diabetic Macular Edema

Week in Review: LaNova Sells Pre-Clinical ADC to AstraZeneca in $600 Million Deal

Week in Review: BlissBio Announces Potential $2 Billion Deal with Eisai for HER2 ADC

Week in Review: Pfizer Picks Sinopharm to Market 12 of its Novel Drugs

Week in Review: Suzhou Duality Out-Licenses Two ADCs to BioNTech in $1.7 Billion Deal

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China